Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine Journal Article


Authors: Flombaum, C. D.; Mouradian, J. A.; Casper, E. S.; Erlandson, R. A.; Benedetti, F.
Article Title: Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine
Abstract: Three patients with pancreatic carcinoma treated with gemcitabine for 1 year developed clinical and laboratory findings compatible with an indolent form of the hemolytic-uremic syndrome. Renal biopsy specimens in two of these patients showed the characteristic features of thrombotic microangiopathy, and a skin biopsy specimen from the third patient, who presented with livedo reticularis, showed intravascular fibrin deposition. Thrombotic microangiopathy may represent a toxic effect of long-term gemcitabine therapy.
Keywords: adult; aged; clinical feature; case report; drug safety; gemcitabine; pancreatic neoplasms; antimetabolites, antineoplastic; skin biopsy; creatinine; pancreas carcinoma; kidney; thrombosis; long term care; microcirculation; deoxycytidine; hemolytic uremic syndrome; thrombotic thrombocytopenic purpura; hemolytic-uremic syndrome; hemoglobins; haptoglobins; thrombotic microangiopathy; humans; human; male; female; article
Journal Title: American Journal of Kidney Diseases
Volume: 33
Issue: 3
ISSN: 0272-6386
Publisher: W.B. Saunders Co.  
Date Published: 1999-03-01
Start Page: 555
End Page: 562
Language: English
PUBMED: 10070921
PROVIDER: scopus
DOI: 10.1016/S0272-6386(99)70194-0
DOI/URL:
Notes: Article -- Export Date: 16 August 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ephraim S Casper
    108 Casper
  2. Robert A Erlandson
    125 Erlandson